Tirzepatide REGENLAB™ – Subcutaneous Injection

For Weight Management & Blood Sugar Control
High-Purity Peptide Formula – Multi-Strength Vials

General Information

Brand Name: REGENLAB™ Tirzepatide
Active Ingredient: Tirzepatide
Concentrations Available:

• 5 mg per vial

• 20 mg per vial

• 60 mg per vial

Dosage Form: Lyophilized powder vial (requires dilution before injection)
Administration: Subcutaneous injection
Packaging: 1 sterile vial per unit
Intended Use: For subcutaneous use only – dilute before injection
Country of Origin: (Not specified on vial — typically manufacturer dependent)

Description

Tirzepatide is a dual GIP/GLP-1 receptor agonist designed to support effective weight reduction, appetite control, and improved insulin sensitivity. By mimicking natural incretin hormones, Tirzepatide helps regulate glucose metabolism while promoting significant fat-loss results when combined with proper diet and lifestyle.

The REGENLAB™ Tirzepatide series offers multiple strength options (5mg – 20mg – 60mg) suitable for different treatment stages, making it ideal for both beginners and advanced users under clinical supervision.

Key Features

• Supports rapid and sustained weight loss

• Reduces appetite and cravings

• Enhances insulin sensitivity & blood sugar regulation

• Once-weekly or protocol-based dosing depending on concentration

• High purity lyophilized formula for safe reconstitution

• Stable and effective incretin-based therapy

• Suitable for clinical, spa, and medical weight-loss programs

Indications

Tirzepatide may be used for:

• Weight reduction in adults with obesity or overweight

• Improving glycemic control in adults with insulin resistance

• Supporting metabolic improvement under medical supervision

(Note: Indications may vary by country. Always follow local medical guidelines.)

Benefits

• Significant and consistent weight loss results

• Appetite suppression leading to lower caloric intake

• Improved blood glucose stability

• Lower risk of hypoglycemia compared to insulin therapies

• Convenient once-weekly dosing (depending on protocol)

• Flexible vial strengths to customize patient treatment plans

Dosage & Administration

Important: Tirzepatide in vial form must be diluted before injection.

Typical protocol (may vary):

• Starting dose: 2.5 mg – 5 mg weekly

• Increase gradually depending on patient tolerance and clinical goal

• Common maintenance doses: 5 mg, 10 mg, 12.5 mg, or 15 mg weekly

Injection route: Subcutaneous — abdomen, thigh, or upper arm.

Only use sterile saline for reconstitution. Shake gently until fully dissolved.

Precautions

• Prescription or professional-use product

• Not recommended for:

  • Pregnant or breastfeeding women

  • Patients with history of thyroid tumors

  • Patients with pancreatitis

• Possible side effects: nausea, diarrhea, vomiting, constipation, decreased appetite

• Monitor patients during dose escalation phases

✨ REGENLAB™ Tirzepatide – Multi-strength clinical formula for effective weight control & metabolic support. ✨